Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Cook

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Trends in Pharmacological Sciences|January 1, 1988
The pharmacology of potassium channels and their therapeutic potentialN S Cook
Journal of Cardiovascular Pharmacology|February 1, 1989
Effect of some potassium channel blockers on contractile responses of the rabbit aortaN S Cook
Life Sciences|January 1, 1988
Leiurus quinquestriatus venom inhibits BRL 34915-induced 86Rb+ efflux from the rat portal veinU Quast, N S Cook
Trends in Pharmacological Sciences|November 1, 1989
Moving together: K+ channel openers and ATP-sensitive K+ channelsU Quast, N S Cook
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamideU Quast, N S Cook
Trends in Pharmacological Sciences|November 1, 1990
Fibrinogen as a major risk factor in cardiovascular diseaseN S Cook, D Ubben
British Journal of Pharmacology|January 1, 1988
Cardiovascular effects of apamin and BRL 34915 in rats and rabbitsN S Cook, R P Hof
British Journal of Pharmacology|September 1, 1985
Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepressionN S Cook, R P Hof
The Journal of Physiology|January 1, 1985
Effects of apamin, quinine and neuromuscular blockers on calcium-activated potassium channels in guinea-pig hepatocytesN S Cook, D G Haylett
Cardiovascular Drugs and Therapy|August 1, 1993
Therapeutic potential of potassium channel openers in peripheral vascular disease and asthmaN S Cook, I D Chapman
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Trends in Pharmacological Sciences|January 1, 1988
The pharmacology of potassium channels and their therapeutic potentialN S Cook
Journal of Cardiovascular Pharmacology|February 1, 1989
Effect of some potassium channel blockers on contractile responses of the rabbit aortaN S Cook
Life Sciences|January 1, 1988
Leiurus quinquestriatus venom inhibits BRL 34915-induced 86Rb+ efflux from the rat portal veinU Quast, N S Cook
Trends in Pharmacological Sciences|November 1, 1989
Moving together: K+ channel openers and ATP-sensitive K+ channelsU Quast, N S Cook
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamideU Quast, N S Cook
Trends in Pharmacological Sciences|November 1, 1990
Fibrinogen as a major risk factor in cardiovascular diseaseN S Cook, D Ubben
British Journal of Pharmacology|January 1, 1988
Cardiovascular effects of apamin and BRL 34915 in rats and rabbitsN S Cook, R P Hof
British Journal of Pharmacology|September 1, 1985
Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepressionN S Cook, R P Hof
The Journal of Physiology|January 1, 1985
Effects of apamin, quinine and neuromuscular blockers on calcium-activated potassium channels in guinea-pig hepatocytesN S Cook, D G Haylett
Cardiovascular Drugs and Therapy|August 1, 1993
Therapeutic potential of potassium channel openers in peripheral vascular disease and asthmaN S Cook, I D Chapman
Pageof 4